Ngā hua rapu - Jonathan Sackner‐Bernstein
- E whakaatu ana i te 1 - 5 hua o te 5
-
1
-
2
-
3
-
4
What Is the Greatest Regulatory Challenge in the Translation of Biomaterials to the Clinic? mā Glenn D. Prestwich, Sangeeta N. Bhatia, Christopher K. Breuer, Shannon L. M. Dahl, Chris Mason, Richard McFarland, David J. McQuillan, Jonathan Sackner‐Bernstein, Jeffrey Schox, William E. Tente, Alan Trounson
I whakaputaina 2012Artigo -
5
Hypertensive End-Organ Damage and Premature Mortality Are p38 Mitogen-Activated Protein Kinase–Dependent in a Rat Model of Cardiac Hypertrophy and Dysfunction mā Thomas M. Behr, Sandhya S. Nerurkar, Allen H. Nelson, Robert W. Coatney, Tina N Woods, Anthony C. Sulpizio, Sudeep Chandra, David P. Brooks, Sanjay Kumar, John C. Lee, Eliot H. Ohlstein, Christiane E. Angermann, Jerry L. Adams, Joseph Sisko, Jonathan Sackner‐Bernstein, Robert N. Willette
I whakaputaina 2001Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Cardiology
Biology
Endocrinology
Heart failure
Acute decompensated heart failure
Afterload
Biomaterial
Biomedical engineering
Blood pressure
Carvedilol
Cell biology
Contractility
Dialysis
Diastole
Ejection fraction
Engineering
Engineering ethics
Gene
Genetics
Heart rate
Inotrope
Kinase
MAPK/ERK pathway
Messenger RNA
Meta-analysis
Muscle hypertrophy
Natriuretic peptide
Nesiritide